ArticleRSC advances2026

Evaluation of novel 1,4-dihydropyridine spirooxindole as antitumor, anti-inflammatory, and antioxidant agents.

Esraa H Al-Afghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.